Meanwhile, in the future, we expect to analyze multiomics data and calculate Jaccard similarity coefficient to explore the level of heterogeneity of SLC25A32 between tumours and patients to increase the clinical translation prospects in different tumours. Here, SLC25A32 is linked to neoplasm.